Avlar BioVentures avlar.com

Avlar is a biotechnology venture capital company which currently has over Euro150 million under management in Avlar BioVentures Fund I, Avlar BioVentures Fund II and the First Cambridge Gateway Fund. The funds are focused on seed and early-stage investments and are used to invest in biopharmaceutical, small molecule drug discovery, epigenetics, medtech and related biotechnology opportunities, and some technology ventures.

Avlar is a biotechnology venture capital company which currently has over Euro150 million under management in Avlar BioVentures Fund I, Avlar BioVentures Fund II and the First Cambridge Gateway Fund. The funds are focused on seed and early-stage inve...Show all

See All Exits Recent Exits

Phone:

Fax:

Highfield Court
Church Lane
 Cambridge, CB23 8AG
 England, United Kingdom

Avlar BioVentures - Investments & Acquisitions

Show Real Data Avlar BioVentures Investments
See all Recent Investments
Date Company Round Amount Co-investors
2011-11-28Medical Device InnovationsSeed VC$0.7MYFM Equity Partners
2009-10-12Crescendo BiologicsSeed VC$7.1MAitua, Sofinnova Partners, and UK Innovation & Science Seed Fund
2007-10-22CellCentricSeries A$4.3MChallenge Fund Trading Company, Morningside Technology Ventures, Nesta, Providence Investment, Takeda Ventures, and UK Innovation & Science Seed Fund
2005-10-25CellCentricSeed VC$0.47MProvidence Investment
2001-06-02SterixUnattributed VC$11M3i Group, Johnson & Johnson Innovation, and Spark Ventures
See all 5 investments